IP Library › Granted Patent US 11,442,062
Granted Patent B2
US 11,442,062 · App. 16/645,862 · Granted Sep 13, 2022

Poly(ethylene glycol) derivative and protein-adsorption inhibitor

Inventors: Akane Katori (Kanagawa, JP); Masaru Matsuda (Kanagawa, JP); Tomozumi Noda (Kanagawa, JP); Takashi Sasaki (Kanagawa, JP); Hirotaka Suzuki (Kanagawa, JP); Nobuyuki Sakamoto (Kanagawa, JP)
Assignee: NOF Corporation
G01N33/531C08G65/3358G01N33/5306
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,442,062
App. No.
16/645,862
Granted
Sep 13, 2022
Kind
B2
Abstract

A compound is provided which is effectively adsorbed to a substrate surface, such as an immune reaction vessel, has extremely high protein adsorption inhibitory effect that inhibits non-specific adsorption of protein or the like, and has excellent washability to retain the inhibitory effect before and after washing operation of the substrate. Also provided are a protein adsorption inhibitor using the compound, a phosphorylcholine-modified substrate, and a method for inhibiting protein adsorption. The compound is a phosphorylcholine group-containing polyethylene glycol derivative represented by formula (1). The method for inhibiting protein adsorption of the present invention includes the step of forming an adsorbed layer of the derivative on a substrate surface.

Claims (6)

1. A phosphorylcholine group-containing polyethylene glycol derivative represented by formula (1):

wherein m is an integer of 1 to 10 and n is an integer of 20 to 200.

2. A protein adsorption inhibitor comprising the phosphorylcholine group-containing polyethylene glycol derivative according to claim 1 , as an active component.

3. A protein adsorption inhibitor solution comprising 0.01 to 20 mass % of the phosphorylcholine group-containing polyethylene glycol derivative according to claim 1 .

4. A phosphorylcholine-modified substrate consisting of a substrate and the phosphorylcholine group-containing polyethylene glycol derivative according to claim 1 , wherein said phosphorylcholine group-containing polyethylene glycol derivative is adsorbed on a surface of the substrate.

5. A method for inhibiting protein adsorption to a substrate, comprising forming an adsorbed layer of a phosphorylcholine group-containing polyethylene glycol derivative by treating a surface of a substrate with the protein adsorption inhibitor solution according to claim 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2020
From: KATORI, AKANE; MATSUDA, MASARU; NODA, TOMOZUMI; SASAKI, TAKASHI; SUZUKI, HIROTAKA; SAKAMOTO, NOBUYUKI
To: NOF CORPORATION
Reel/Frame 052341/0681 →
Priority Claims (1)
JP JP2017-173725 · Sep 11, 2017 · national
Continuity (1)
Related Publication 20200271642A1 · Aug 27, 2020